AxoSim announced today, Stuart Gibb as our VP of Sales and Marketing. He brings over 20 years of global sales leadership experience, with a demonstrated track record of scaling revenue for high-growth startups and multi-billion-dollar organizations.? Excited to have Stuart join the team!? Full Press Release here: bit.ly/4eqD9XV
关于我们
AxoSim empowers advancements in human neuroscience by partnering with biopharma companies to facilitate breakthroughs in devastating neurological diseases and disorders. Their proprietary drug discovery platforms NerveSim?, BrainSim?, and microBrain? deliver clinically-relevant data to select better lead candidates with phenotypically accurate assays. AxoSim's platforms have applications in peripheral neuropathy and neuropathic pain, disease modeling (such as ALS, MS, and CMT), and neurotoxicology. Is your organization interested in learning more about what we do? Please email us at [email protected].
- 网站
-
https://www.axosim.com
AxoSim的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- New Orleans，LA
- 类型
- 私人持股
- 创立
- 2014
- 领域
- Drug Developent、Preclinical Testing、Neurotoxicity、Neuroefficacy、3D Cell Assays、Neurodegenerative Disease Models、Myelination Models、Nerve-on-a-Chip、Organ-on-a-Chip、Peripheral Neuropathy、Toxicology、Neuroscience和organoids
地点
-
主要
获取路线
1441 Canal Street
US，LA，New Orleans，70112
AxoSim员工
动态
-
?? Media Alert! Check out CEO Alif Saleh's interview in PharmaVoice discussing neuro drug development and AxoSim.
While enthusiasm is high in the push to develop new drugs for neurological disorders like epilepsy, #Alzheimer’s and #Parkinson’s disease, the vast majority of investigational medications still don’t make it far — and 92% fail when they reach human testing. “Neuro has one of the highest failure rates and one of the highest investment rates and that means something is wrong,” said Alif Saleh, CEO of AxoSim, a Louisiana-based biotech with a brain-on-a-chip platform. https://lnkd.in/e_8NeaRp
-
Athletes are known for their strength and speed, but to compete at an elite level, their brains must connect with their bodies to enable precise motor function. AxoSim wishes athletes across the globe a safe, meaningful, and victorious Olympics. Pictured: Our creative take on the Olympic rings using immunofluorescent neurons of our brain organoids #fluorescencefriday #microscopy #olympics
-
-
It was an honor to present yesterday at #ADCTox. If you missed the presentation or want to learn more about AxoSim, stop by our booth to see Megan Terral and Amit Johal.
-
-
We are currently hiring for two new positions:?Marketing Manager?(Boston) and?IT Systems Administrator?(Maple Grove). Are you the right candidate for our team? Learn more about open positions: https://lnkd.in/gcmQqhQs
-
-
AxoSim Director of Scientific Operations, Megan Terral, will be speaking next week at #ADCTox in Boston. Will we see you there? ?? High-throughput Functional and Morphological Neurotoxicity Screening in Human NerveSim? ?? Wednesday, July 24, 2:45 PM EST
-
-
AxoSim is currently hiring an information technology systems administrator to work in our Upriver lab in Maple Grove, Minnesota. The IT systems administrator role involves managing on-premise and cloud servers, network systems, end-user hardware and software, email security, and other critical systems. https://lnkd.in/gccTZyBx
-
AxoSim is currently hiring a Boston-based marketing manager. In this role, the marketing manager will execute AxoSim's strategy to bring our neurological drug discovery platforms to market.?A PhD in neurology and a minimum of 10 years of experience working in a marketing management position for a commercial?in vitro?platform services company are preferred. https://lnkd.in/gMJ9WuTm
-
For those who weren't able to attend or would like more time to evaluate the data, we have made our posters from the MPS World Summit available on our website: https://lnkd.in/gyANrYvZ #mps #mps2024 #mpsworldsummit #organoids
-
-
Brightfield images of NerveSim? before (DIV43) and after (DIV50) dosing with 100 nM Vincristine. A dose range was performed, yielding quantifiable nerve fiber degeneration to produce an IC50 for the three image analysis metrics below. #microscopymonday #moleculardevices Molecular Devices
-